Christophe Marçais

1.6k total citations
28 papers, 1.1k citations indexed

About

Christophe Marçais is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Christophe Marçais has authored 28 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 10 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Molecular Biology. Recurrent topics in Christophe Marçais's work include Lipid metabolism and disorders (14 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers) and Lysosomal Storage Disorders Research (4 papers). Christophe Marçais is often cited by papers focused on Lipid metabolism and disorders (14 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers) and Lysosomal Storage Disorders Research (4 papers). Christophe Marçais collaborates with scholars based in France, United States and Japan. Christophe Marçais's co-authors include Mehmet Öztürk, Gilles Millat, David A. Wenger, Marie T. Vanier, Cengiz Yakıcıer, Philippe Moulin, Catherine Tomasetto, K. Harzer, Kinji Ohno and K. J. Isselbacher and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Christophe Marçais

26 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christophe Marçais France 16 366 344 257 219 192 28 1.1k
Dale Newland United States 10 425 1.2× 85 0.2× 109 0.4× 177 0.8× 196 1.0× 14 1.2k
Jean‐Marc Herbert France 18 403 1.1× 99 0.3× 426 1.7× 53 0.2× 92 0.5× 37 1.2k
J. P. Farriaux France 24 682 1.9× 392 1.1× 48 0.2× 124 0.6× 114 0.6× 90 1.7k
Mercedes N. Munkonda Canada 15 308 0.8× 108 0.3× 100 0.4× 72 0.3× 157 0.8× 20 803
Sanae Teshigawara Japan 16 341 0.9× 167 0.5× 90 0.4× 107 0.5× 280 1.5× 30 934
Céline Gheeraert France 15 536 1.5× 130 0.4× 53 0.2× 93 0.4× 290 1.5× 25 906
Kathrin Heermeier Germany 14 386 1.1× 147 0.4× 102 0.4× 74 0.3× 51 0.3× 18 891
A Yoshida Japan 19 433 1.2× 258 0.8× 44 0.2× 79 0.4× 163 0.8× 59 1.2k
Margaret A. Morris United States 18 525 1.4× 131 0.4× 52 0.2× 186 0.8× 98 0.5× 27 1.1k
Jan Willem N. Akkerman Netherlands 18 254 0.7× 110 0.3× 280 1.1× 135 0.6× 84 0.4× 29 1.2k

Countries citing papers authored by Christophe Marçais

Since Specialization
Citations

This map shows the geographic impact of Christophe Marçais's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Marçais with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Marçais more than expected).

Fields of papers citing papers by Christophe Marçais

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christophe Marçais. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Marçais. The network helps show where Christophe Marçais may publish in the future.

Co-authorship network of co-authors of Christophe Marçais

This figure shows the co-authorship network connecting the top 25 collaborators of Christophe Marçais. A scholar is included among the top collaborators of Christophe Marçais based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christophe Marçais. Christophe Marçais is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bergeron, Jean, Diane Brisson, Nathalie Laflamme, et al.. (2025). Acute pancreatitis during pregnancy in women with chylomicronemia. Atherosclerosis. 407. 119612–119612.
2.
Charrière, Sybil, Thomas Simonet, Véronique Bonnet, et al.. (2018). Single, short in‐del, and copy number variations detection in monogenic dyslipidemia using a next‐generation sequencing strategy. Clinical Genetics. 94(1). 132–140. 15 indexed citations
3.
Cuerq, Charlotte, Émilie Hénin, Lioara Restier, et al.. (2018). Efficacy of two vitamin E formulations in patients with abetalipoproteinemia and chylomicron retention disease. Journal of Lipid Research. 59(9). 1640–1648. 13 indexed citations
4.
Filippo, Mathilde Di, et al.. (2017). Alterations in plasma triglycerides lipolysis in patients with history of multifactorial chylomicronemia. Atherosclerosis. 265. 22–28. 10 indexed citations
5.
Marçais, Christophe, Delphine Maucort‐Boulch, Jocelyne Drai, et al.. (2017). Circulating Klotho Associates With Cardiovascular Morbidity and Mortality During Hemodialysis. The Journal of Clinical Endocrinology & Metabolism. 102(9). 3154–3161. 46 indexed citations
6.
7.
Caussy, Cyrielle, Sybil Charrière, Christophe Marçais, et al.. (2014). An APOA5 3′ UTR Variant Associated with Plasma Triglycerides Triggers APOA5 Downregulation by Creating a Functional miR-485-5p Binding Site. The American Journal of Human Genetics. 94(1). 129–134. 48 indexed citations
8.
Marçais, Christophe, Françoise Descôtes, Éric Piaton, et al.. (2010). Quantitative Loss of Heterozygosity Analysis for Urothelial Carcinoma Detection and Prognosis. Urology. 76(2). 515.e1–515.e7. 7 indexed citations
9.
Charrière, Sybil, Sophie Bernard, L. Groisne, et al.. (2009). Modulation of phenotypic expression of APOA5 Q97X and L242P mutations. Atherosclerosis. 207(1). 150–156. 16 indexed citations
10.
Charrière, Sybil, et al.. (2008). Association of APOA5 −1131T>C and S19W gene polymorphisms with both mild hypertriglyceridemia and hyperchylomicronemia in type 2 diabetic patients. Clinica Chimica Acta. 394(1-2). 99–103. 24 indexed citations
11.
Marçais, Christophe, et al.. (2005). Combination of Circulating Antilipoprotein Lipase (Anti-LPL) Antibody and Heterozygous S172 fsX179 Mutation of LPL Gene Leading to Chronic Hyperchylomicronemia. The Journal of Clinical Endocrinology & Metabolism. 90(7). 3995–3998. 25 indexed citations
12.
Marçais, Christophe. (2005). Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment. Journal of Clinical Investigation. 115(10). 2862–2869. 119 indexed citations
13.
Pittis, María Gabriela, Veronica Ileana Guerci, Christophe Marçais, et al.. (2004). Acid sphingomyelinase: Identification of nine novel mutations among Italian Niemann Pick type B patients and characterization ofin vivofunctional in-frame start codon. Human Mutation. 24(2). 186–187. 43 indexed citations
14.
Ponsin, Gabriel, Christophe Marçais, Laurence Duvillard, et al.. (2001). Ex VivoMeasurement of Lipoprotein Lipase-Dependent Very Low Density Lipoprotein (VLDL)-Triglyceride Hydrolysis in Human VLDL: An Alternative to the Postheparin Assay of Lipoprotein Lipase Activity?1. The Journal of Clinical Endocrinology & Metabolism. 86(2). 797–803. 23 indexed citations
15.
Millat, Gilles, Christophe Marçais, Catherine Tomasetto, et al.. (2001). Niemann-Pick C1 Disease: Correlations between NPC1 Mutations, Levels of NPC1 Protein, and Phenotypes Emphasize the Functional Significance of the Putative Sterol-Sensing Domain and of the Cysteine-Rich Luminal Loop. The American Journal of Human Genetics. 68(6). 1373–1385. 157 indexed citations
16.
Marçais, Christophe, et al.. (2000). Severe hypertriglyceridaemia in Type II diabetes: involvement of apoC-III Sst-I polymorphism, LPL mutations and apo E3 deficiency. Diabetologia. 43(11). 1346–1352. 25 indexed citations
17.
Vanier, M. T., Gilles Millat, Christophe Marçais, et al.. (1999). Niemann-Pick C disease : insight from studies on mutated NPC1 gene and protein. 15(2). 120. 1 indexed citations
18.
Millat, Gilles, Christophe Marçais, Mohammad A. Rafi, et al.. (1999). Niemann-Pick C1 Disease: The I1061T Substitution Is a Frequent Mutant Allele in Patients of Western European Descent and Correlates with a Classic Juvenile Phenotype. The American Journal of Human Genetics. 65(5). 1321–1329. 144 indexed citations
19.
Moyret‐Lalle, Caroline, Christophe Marçais, Jocelyne Jacquemier, et al.. (1995). ras, p53 and hpv status in benign and malignant prostate tumors. International Journal of Cancer. 64(2). 124–129. 60 indexed citations
20.
Mazoyer, Sylvie, Philippe Lalle, Caroline Moyret‐Lalle, et al.. (1994). Two germ-line mutations affecting the same nucleotide at codon 257 of p53 gene, a rare site for mutations.. HAL (Le Centre pour la Communication Scientifique Directe). 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dale Newland Breakdown of academic impact, for papers by Jean‐Marc Herbert Breakdown of academic impact, for papers by J. P. Farriaux Breakdown of academic impact, for papers by Mercedes N. Munkonda Breakdown of academic impact, for papers by Sanae Teshigawara Breakdown of academic impact, for papers by Céline Gheeraert Breakdown of academic impact, for papers by Kathrin Heermeier Breakdown of academic impact, for papers by A Yoshida Breakdown of academic impact, for papers by Margaret A. Morris Breakdown of academic impact, for papers by Jan Willem N. Akkerman
Rankless by CCL
2026